Oct 2016

COSMOSID ANNOUNCES ONCOBIOME PARTNERSHIP WITH THE WHITE HOUSE CANCER MOONSHOT INITIATIVE

COSMOSID ANNOUNCES ONCOBIOME PARTNERSHIP WITH THE WHITE HOUSE CANCER MOONSHOT INITIATIVE

Rockville, MD, October 17, 2016 – Today CosmosID  announcedparticipation in Vice President Biden’s  National Cancer Moonshot, which aims to accelerate progress in preventing, diagnosing, and treating cancer. CosmosID will provide access to its automated bioinformatics platform, MetaGenID, for five cancer microbiome research studies (valued at $150,000) to understand how the microbiome (i.e. oral, gut, and skin) contributes to development of specific cancers.